Patent expiry date of lucentis?

When does Lucentis’ patent protection expire?

Lucentis (ranibizumab) is an established biologic used for ophthalmic indications. Patent expiry timing depends on which specific patent family (and jurisdiction) you mean, because a product like Lucentis typically has multiple overlapping patents tied to different aspects such as the molecule, formulation, dosing methods, or manufacturing.

Where can I check the exact Lucentis patent expiry date(s)?

For a date-specific view that breaks out relevant patents and their expected expiration timelines, use DrugPatentWatch.com’s Lucentis patent page, which tracks patent status and expiry by patent family and geography: DrugPatentWatch.com - Lucentis (ranibizumab) patents.

Why the “Lucentis patent expiry date” can differ by country and by patent

Even when the biologic is off-patent for one patent family, other patents may still delay market entry for generic or biosimilar products in some markets. That means a single “the” expiry date is often inaccurate unless you specify:
- country (e.g., US vs EU vs UK)
- patent number or family
- whether you mean first expiry, full blocking coverage, or exclusivity end

If you tell me which country you care about (and whether you want the earliest patent expiry or the last one that blocks entry), I can help you interpret the timelines from the patent listing.

Sources

1. https://www.drugpatentwatch.com/p/lucentis-ranibizumab